-
The study found no increased risk of cancer, deep vein thrombosis or stroke.
FORBES: Connect
-
The label now includes a black box warning that it can increase the risk of death, MI, stroke, venous thromboembolism, thrombosis of vascular access, and tumor progression or recurrence.
FORBES: Amgen Pleads Guilty To Misbranding Anemia Drug Aranesp
-
As with combination therapy, the risk of fractures is lower, but there is an increased risk of stroke, gallbladder disease, deep vein thrombosis and urinary incontinence.
CNN: Government panel: Hormone therapy 'not recommended'